BDTX
Black Diamond Therapeutics, Inc.NASDAQHealthcare$2.39+2.58%ClosedMarket Cap: $136.9M
As of 2026-04-06
Valuation
P/E (TTM)
6.12
PEG
0.05
P/B
1.27
P/S
2.05
EV/EBITDA
5.38
DCF Value
$10.86
FCF Yield
20.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.8%
Operating Margin
28.4%
Net Margin
32.0%
ROE
17.5%
ROA
15.6%
ROIC
15.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-10.3M | $-15.1M | $-0.26 | — |
| FY 2025 | $70.0M | 99.5% | $19.9M | $22.4M | $0.39 | — |
| Q3 2025 | $0.00 | NaN% | $-11.0M | $-8.5M | $-0.15 | — |
| Q2 2025 | $0.00 | -Infinity% | $-13.4M | $-10.6M | $-0.19 | — |
| Q1 2025 | $70.0M | 100.0% | $54.5M | $56.5M | $0.98 | — |
| Q4 2024 | $0.00 | NaN% | $-18.3M | $-16.0M | $-0.28 | — |
| FY 2024 | $0.00 | NaN% | $-78.8M | $-69.7M | $-1.27 | — |
| Q3 2024 | $0.00 | NaN% | $-18.1M | $-15.6M | $-0.28 | — |
| Q2 2024 | $0.00 | -Infinity% | $-22.1M | $-19.9M | $-0.36 | — |
| Q1 2024 | $0.00 | -Infinity% | $-20.2M | $-18.2M | $-0.35 | — |
| Q4 2023 | $0.00 | NaN% | $-20.9M | $-19.4M | $-0.41 | — |
| FY 2023 | $0.00 | -Infinity% | $-86.5M | $-82.4M | $-1.88 | — |